Mortality in Spanish pediatric emergency departments: a 5-year multicenter survey

Edurne Lopez1, June Udaondo, Mikel Olabarri

  • 1Pediatric Emergency Department, Cruces University Hospital, University of the Basque, Country, Basque Country, Spain.

Insights

In Spanish pediatric emergency departments, the primary causes of child mortality include pre-existing conditions, sudden infant death syndrome, and trauma. Improving prehospital and emergency care is crucial for these vulnerable patients.

Area of Science:

  • Pediatric Emergency Medicine
  • Public Health
  • Child Mortality Analysis

Background:

  • Child mortality in pediatric emergency departments (EDs) requires analysis to inform management and prevention strategies.
  • Understanding causes of death is vital for improving pediatric emergency care.

Purpose of the Study:

  • To identify the leading causes of death in children within Spanish pediatric EDs.
  • To examine the prehospital and hospital management of critically ill children.

Main Methods:

  • Retrospective, descriptive, multicenter survey of pediatric deaths.
  • Data collected from 18 Spanish pediatric EDs between 2008 and 2013.
  • Analysis included patient demographics, causes of death, and resuscitation efforts.

Main Results:

  • A total of 54 pediatric deaths occurred among over 3.5 million visits (mortality rate: 1.5/100,000).
  • Leading causes of death were previous illnesses (24.5%), sudden infant death syndrome (20.7%), and trauma (18.8%).
  • Cardiopulmonary resuscitation (CPR) was frequently administered, particularly in medically transported patients.

Conclusions:

  • Key drivers of pediatric mortality in Spanish EDs are chronic conditions, SIDS, and unintentional injuries.
  • Enhancements in prehospital and emergency care protocols are recommended to improve outcomes for critically ill children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
372
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
461
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
702
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
733
Life Tables01:22

Life Tables

A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
630